Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation

Detalles Bibliográficos
Autores principales: Asawapanumas, Thiti, Chanswangphuwana, Chantiya, Watanaboonyongcharoen, Phandee, Rojnuckarin, Ponlapat, Bunworasate, Udomsak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059067/
https://www.ncbi.nlm.nih.gov/pubmed/35509968
http://dx.doi.org/10.1016/j.lrr.2022.100314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059067/
https://www.ncbi.nlm.nih.gov/pubmed/35509968
http://dx.doi.org/10.1016/j.lrr.2022.100314

Ejemplares similares